BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasaki H, Saisho Y, Inaishi J, Itoh H. Revisiting Regulators of Human β-cell Mass to Achieve β-cell-centric Approach Toward Type 2 Diabetes. J Endocr Soc 2021;5:bvab128. [PMID: 34405128 DOI: 10.1210/jendso/bvab128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Okaiyeto K, Kerebba N, Oguntibeju OO. UPLC-ESI-QTOF-MS Profiling of Phenolic Compounds from Eriocephalus africanus: In Vitro Antioxidant, Antidiabetic, and Anti-Inflammatory Potentials. Molecules 2022;27. [PMID: 36558046 DOI: 10.3390/molecules27248912] [Reference Citation Analysis]
2 Abderrahmani A, Jacovetti C, Regazzi R. Lessons from neonatal β-cell epigenomic for diabetes prevention and treatment. Trends Endocrinol Metab 2022;33:378-89. [PMID: 35382967 DOI: 10.1016/j.tem.2022.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]